SCHEMBL1021283

SCHEMBL1021283

COC(=O)OC1c2ccc(OCCN3CCCCC3)cc2CCN1S(=O)(=O)c1ccc(Oc2ccc(OC)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.53
ESR2 Q92731 4/20 0.53
MMP1 P03956 6/20 0.50
MMP9 P14780 6/20 0.50
MMP2 P08253 3/20 0.50
MMP12 P39900 3/20 0.50
MMP14 P50281 3/20 0.50
MMP15 P51511 3/20 0.50
MMP16 P51512 3/20 0.50
MMP26 Q9NRE1 3/20 0.50
MMP7 P09237 2/20 0.50
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HRH3 Q9Y5N1 6/20 0.45
TAS2R14 Q9NYV8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1021326 0.94 ESR1 (0.51) ESR1ESR2MMP1MMP9MMP2
SCHEMBL1023175 0.93 ESR1 (0.55) ESR1ESR2MMP1MMP9MMP2
SCHEMBL1021277 0.92 MMP1 (0.53) ESR1ESR2MMP1MMP9MMP2
SCHEMBL3535505 0.87 MMP1 (0.55) ESR1ESR2MMP1MMP9MMP2
SCHEMBL1019860 0.86 EPHX2 (0.46) ESR1ESR2MMP1MMP9MMP2
SCHEMBL1023173 0.86 MMP1 (0.56) ESR1ESR2MMP1MMP9MMP2
SCHEMBL1020994 0.85 MMP1 (0.50) MMP1MMP9MMP2MMP12MMP14
SCHEMBL3536039 0.85 MMP1 (0.67) ESR1ESR2MMP1MMP9MMP2
SCHEMBL1021973 0.85 MMP1 (0.47) MMP1MMP9MMP2MMP12MMP14
SCHEMBL1022000 0.85 MEN1 (0.46) ESR1ESR2MMP1MMP9MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869001-B1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI AVENTIS (FR) 2011-01-12 EP disclosed
EP-1869001-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE Sanofi-Aventis (FR) 2007-12-26 EP disclosed
WO-2006102998-A1 SUBSTITUTED TETRAHYDROISOCHINOLINES AS MMP INHIBITORS, RELATED PRODUCTION METHOD AND USE AS MEDICINE SANOFI-AVENTIS (DE) 2006-10-05 WO disclosed